1. Home
  2. MDA vs AMRX Comparison

MDA vs AMRX Comparison

Compare MDA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDA

MDA Space Ltd. Common Shares

N/A

Current Price

$32.24

Market Cap

4.2B

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.55

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDA
AMRX
Founded
1969
2002
Country
Canada
United States
Employees
4000
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
MDA
AMRX
Price
$32.24
$12.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$37.50
$15.60
AVG Volume (30 Days)
689.6K
1.3M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.22
Revenue
N/A
N/A
Revenue This Year
$12.11
$4.48
Revenue Next Year
$11.03
$7.13
P/E Ratio
N/A
$57.32
Revenue Growth
N/A
N/A
52 Week Low
$23.23
$7.02
52 Week High
$37.45
$15.42

Technical Indicators

Market Signals
Indicator
MDA
AMRX
Relative Strength Index (RSI) 49.87 45.67
Support Level $23.23 $12.50
Resistance Level $33.75 $12.85
Average True Range (ATR) 1.75 0.49
MACD 0.23 0.01
Stochastic Oscillator 44.63 28.01

Price Performance

Historical Comparison
MDA
AMRX

About MDA MDA Space Ltd. Common Shares

MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: